Evidence map›Paper›PMID 32778055›Full record

ArticleBMC anesthesiology2020

Deep sedation using propofol target-controlled infusion for gastrointestinal endoscopic procedures: a retrospective cohort study.

María E García Guzzo, María S Fernandez, Delfina Sanchez Novas, Sandra S Salgado, Sergio A Terrasa, Gonzalo Domenech, Carlos A Teijido

Abstract read
In one paragraph

Article in BMC anesthesiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

María E García GuzzoDepartment of Anesthesiology, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Presidente Teniente General Juan Domingo Perón 4190, 1199, Buenos Aires, Argentina. mariae.garcia@hospitalitaliano.org.ar.
María S FernandezDepartment of Anesthesiology, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Presidente Teniente General Juan Domingo Perón 4190, 1199, Buenos Aires, Argentina.
Delfina Sanchez NovasDepartment of Anesthesiology, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Presidente Teniente General Juan Domingo Perón 4190, 1199, Buenos Aires, Argentina.
Sandra S SalgadoDepartment of Anesthesiology, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Presidente Teniente General Juan Domingo Perón 4190, 1199, Buenos Aires, Argentina.
Sergio A TerrasaDepartment of Research, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Presidente Teniente General Juan Domingo Perón 4190, 1199, Buenos Aires, Argentina.
Gonzalo DomenechDepartment of Anesthesiology, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Presidente Teniente General Juan Domingo Perón 4190, 1199, Buenos Aires, Argentina.
Carlos A TeijidoDepartment of Anesthesiology, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Presidente Teniente General Juan Domingo Perón 4190, 1199, Buenos Aires, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPropofol sedation is effective for gastrointestinal endoscopic procedures, but its narrow therapeutic window highlights the importance of identifying an optimal administration technique regarding effectiveness and safety. This study aimed to determine the incidence of significant adverse events in adult patients scheduled for gastrointestinal endoscopy under anaesthetist-performed sedation using propofol target-controlled infusion and determine the existence of associations between these events and potentially related variables.

methodsThis single-centre, retrospective cohort study took place in a tertiary referral university hospital. Medical records of 823 patients (age > 18 years, American Society of Anesthesiologists physical status classification scores I-III) who had undergone elective gastrointestinal endoscopy under propofol target-controlled infusion sedation during September 2018 were reviewed. Outcomes included hypoxia, hypotension, and bradycardia events, requirement of vasoactive drugs, unplanned tracheal intubation or supraglottic device insertion, and need for advanced cardiac life support.

resultsThe most frequently encountered adverse event was oxygen desaturation < 95% with an incidence of 22.35%. Vasoactive drug administration, hypotension, and oxygen desaturation < 90% followed, with incidences of 19.2, 12.64, and 9.92%, respectively. Only 0.5% of patients required advanced airway management. Multivariate analysis revealed an association between hypotension events, colonoscopic procedures, and propofol doses (odds ratio: 3.08, 95% confidence interval: 1.43 to 6.61; P = 0.004 and odds ratio: 1.14, 95% confidence interval: 1.00 to 1.29; P = 0.046). A strong dose-effect relationship was found between hypoxia and obesity; patients with body mass index ≥40 were nine times (odds ratio: 10.22, 95% confidence interval: 2.83 to 36.99) more likely to experience oxygen desaturation < 90% events.

conclusionsPropofol sedation using target-controlled infusion appears to be a safe and effective anaesthetic technique for gastrointestinal endoscopic procedures with acceptable rates of adverse events and could be more widely adopted in clinical practice.

Indexed as

AgedAnesthetics, IntravenousCohort StudiesDeep SedationDrug Delivery SystemsEndoscopy, GastrointestinalFemaleHumansHypotensionMaleMiddle AgedPostoperative PainPropofolRetrospective StudiesAnesthetics, IntravenousPropofolAnaesthesia, intravenousAnaesthesiologistsDeep sedationEndoscopyGastrointestinalPropofol

Identifiers

PMID32778055
PMCPMC7418437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.